Testing a new shingles vaccine for adults over 40
Treatments studied
Part of Infections, Skin clinical trials.
This study tests a new vaccine to protect against shingles (herpes zoster), a painful skin infection that can affect people as they age. You would receive the vaccine and be monitored to see if it's safe and how your body responds.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years old or older
- You have never had shingles or chickenpox vaccine before
- You do not have a fever or acute illness on the day of vaccination
- You do not have a weakened immune system or certain serious health conditions
- You are not pregnant, breastfeeding, or planning to become pregnant during the trial
- You have not received other vaccines or blood products in the past 1–3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new shingles vaccine to see how well it prevents shingles in adults aged 40 and older. It aims to help those who have not had shingles recently or been vaccinated against it before.
This trial tests a new shingles vaccine (LYB004) in adults 40 and older. It looks at how safe the vaccine is and how well it helps your body build protection against shingles.
This trial tests a new shingles vaccine in adults 40 and older to see if it is safe and works well. The vaccine is designed to prevent shingles and its complications, which are common in this age group.
This trial tests an experimental vaccine designed to prevent shingles (a painful rash caused by the varicella-zoster virus). It will help see if the vaccine is safe and triggers a good immune response in adults 40 and older.
This trial tests a new shingles vaccine for healthy adults 40 and older. It aims to see if the vaccine is safe and helps protect against shingles.
This study tests an investigational vaccine (SYS6017) to see how well it works and if it's safe for adults 40 and older. The vaccine aims to prevent shingles, a painful rash caused by the same virus as chickenpox.
Hear when a new Herpes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.